BIP Wealth LLC Has $715,000 Stock Holdings in The Procter & Gamble Company (NYSE:PG)

BIP Wealth LLC grew its position in shares of The Procter & Gamble Company (NYSE:PG) by 34.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,881 shares of the company’s stock after purchasing an additional 1,245 shares during the quarter. BIP Wealth LLC’s holdings in Procter & Gamble were worth $715,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the company. Demars Financial Group LLC boosted its holdings in shares of Procter & Gamble by 4.4% in the 4th quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock worth $219,000 after purchasing an additional 63 shares in the last quarter. Emerald Advisors LLC boosted its holdings in shares of Procter & Gamble by 1.8% in the 4th quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock worth $553,000 after purchasing an additional 65 shares in the last quarter. O Brien Wealth Partners LLC boosted its holdings in shares of Procter & Gamble by 3.3% in the 4th quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after purchasing an additional 65 shares in the last quarter. KFA Private Wealth Group LLC boosted its holdings in shares of Procter & Gamble by 2.2% in the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock worth $445,000 after purchasing an additional 67 shares in the last quarter. Finally, Chemistry Wealth Management LLC boosted its holdings in Procter & Gamble by 1.2% during the 4th quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock valued at $856,000 after acquiring an additional 67 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction on Monday, January 29th. The stock was sold at an average price of $156.00, for a total transaction of $7,020,000.00. Following the completion of the transaction, the chief executive officer now owns 973 shares in the company, valued at $151,788. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction on Monday, January 29th. The stock was sold at an average price of $156.00, for a total transaction of $7,020,000.00. Following the completion of the transaction, the chief executive officer now owns 973 shares in the company, valued at $151,788. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the transaction, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 100,865 shares of company stock worth $16,029,280. 0.17% of the stock is owned by insiders.

Procter & Gamble Stock Up 0.4 %

Shares of NYSE:PG traded up $0.59 during trading on Thursday, hitting $163.19. The stock had a trading volume of 3,464,353 shares, compared to its average volume of 6,925,487. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $164.32. The company has a market capitalization of $385.15 billion, a PE ratio of 26.64, a PEG ratio of 3.28 and a beta of 0.44. The firm’s fifty day moving average is $159.46 and its 200 day moving average is $153.32. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. During the same quarter in the prior year, the company earned $1.37 EPS. The business’s revenue was up .6% compared to the same quarter last year. Analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $1.0065 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.47%. Procter & Gamble’s payout ratio is presently 65.85%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PG. Deutsche Bank Aktiengesellschaft dropped their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a report on Monday. Barclays increased their target price on Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a report on Tuesday. Argus increased their target price on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a report on Thursday. Wells Fargo & Company increased their target price on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Finally, Jefferies Financial Group increased their target price on Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a report on Monday. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $169.76.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.